Cybin to Participate in Upcoming Scientific and Investor Conferences
Cybin Inc. , a biopharmaceutical company focused on progressing Psychedelics to TherapeuticsTM, is pleased to announce its participation in the following upcoming conferences: Interdisciplinary... | September 21, 2022